about
HER2 and uPAR cooperativity contribute to metastatic phenotype of HER2-positive breast cancerSecretory leukocyte protease inhibitor (SLPI) expression and tumor invasion in oral squamous cell carcinomaPlasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity.MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression.Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.Down-regulation of SerpinB2 is associated with gefitinib resistance in non-small cell lung cancer and enhances invadopodia-like structure protrusions.Plasminogen receptors: the first quarter century.Bacterial plasminogen receptors: mediators of a multifaceted relationship.From plasminogen to plasmin: role of plasminogen receptors in human cancer.The role of annexin A2 in tumorigenesis and cancer progressionThe urokinase plasminogen activation system in gastroesophageal cancer: A systematic review and meta-analysis.Improved pharmacokinetic and biodistribution properties of the selective urokinase inhibitor PAI-2 (SerpinB2) by site-specific PEGylation: implications for drug delivery.Identification of interconnected markers for T-cell acute lymphoblastic leukemiaHDL-C, ABCA1-mediated cholesterol efflux, and lipoprotein(a): insights into a potential novel physiologic role of lipoprotein(a).Clinical significance of annexin II expression in human non-small cell lung cancer.Molecular changes consistent with increased proliferation and invasion are common in rectal cancer.Proteolytic enzyme activity as a result of aging.Amorphous protein aggregates stimulate plasminogen activation, leading to release of cytotoxic fragments that are clients for extracellular chaperones.Identification and Comparison of Differentiation-Related Proteins in Hepatocellular Carcinoma Tissues by Proteomics.
P2860
Q28085413-5DEFF5A9-1EA7-45FA-AA18-792A625AFBE0Q35071264-5808B288-B4A3-41CA-8FC0-7C7A59D67AE0Q35749341-53D4DDFA-C342-4DA4-95AA-E789FC246487Q35953723-56B83A53-8E7F-4201-8628-380212F26CDDQ36207160-FDC03389-71DA-4545-8702-040E686EC1BEQ37203214-018D809E-758D-41E9-835E-3D2FF4540727Q37609916-7D5423F8-5EA5-47AB-A2B7-86FADC473048Q38057217-40FA66B5-779A-46CF-8487-C5ACEFC1CA3FQ38269342-D1445AC3-E4E2-4AD5-B1B0-AC9B88E53802Q38366258-EBDF4FD4-BC8B-493A-9ECF-4BFEE796B0F6Q38833520-ABC02C22-AC58-4FF1-8E37-5D3BE8959108Q38955588-155B62FC-2375-441E-AF8A-BDC9491FA30BQ41969078-724979C3-11CB-41D8-83D4-5E67FA4BED21Q42408461-94145102-7ABC-4EDC-B93C-C5CFC7B409E1Q43490599-CC799F80-EA54-4AC2-ADDF-73858CFB64C1Q45120532-C69D1A5A-2AD0-44B8-875B-E8EF7441F500Q46118223-8EA7BD8A-458C-4417-8645-BCA7AC023280Q48122550-38716471-0857-437E-A83F-592F8C5C74DFQ49166081-B083015D-AD22-41BE-AFFB-5248F6688957
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Plasminogen binding and cancer: promises and pitfalls.
@ast
Plasminogen binding and cancer: promises and pitfalls.
@en
Plasminogen binding and cancer: promises and pitfalls.
@nl
type
label
Plasminogen binding and cancer: promises and pitfalls.
@ast
Plasminogen binding and cancer: promises and pitfalls.
@en
Plasminogen binding and cancer: promises and pitfalls.
@nl
prefLabel
Plasminogen binding and cancer: promises and pitfalls.
@ast
Plasminogen binding and cancer: promises and pitfalls.
@en
Plasminogen binding and cancer: promises and pitfalls.
@nl
P356
P1476
Plasminogen binding and cancer: promises and pitfalls.
@en
P2093
Nicholas M Andronicos
P304
P356
10.2741/1044
P50
P577
2003-05-01T00:00:00Z